Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TBC1D31 mRNA] | CTD | PMID:31150632 | 1,1-dichloroethene | increases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of TBC1D31 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of WDR67 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TBC1D31 mRNA | CTD | PMID:21889950 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TBC1D31 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Tbc1d31 (Mus musculus) | 6480464 | [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of TBC1D31 mRNA | CTD | PMID:25975270 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TBC1D31 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TBC1D31 mRNA | CTD | PMID:21570461 | 2-methylcholine | affects expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of TBC1D31 mRNA | CTD | PMID:21179406 | 4-hydroxynon-2-enal | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of TBC1D31 mRNA | CTD | PMID:19191707 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of TBC1D31 mRNA | CTD | PMID:30047161 | aflatoxin B1 | affects expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of TBC1D31 protein | CTD | PMID:20106945 | all-trans-retinoic acid | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of TBC1D31 mRNA | CTD | PMID:33167477 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of TBC1D31 mRNA | CTD | PMID:30047161 | benzo[a]pyrene | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of TBC1D31 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | decreases methylation | ISO | TBC1D31 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of WDR67 promoter | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of TBC1D31 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of TBC1D31 mRNA | CTD | PMID:32156529 | bisphenol A | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of TBC1D31 mRNA | CTD | PMID:33670352 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of TBC1D31 mRNA | CTD | PMID:32145629 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TBC1D31 mRNA | CTD | PMID:30816183 more ... | bisphenol A | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of TBC1D31 mRNA | CTD | PMID:20678512 | bisphenol F | increases methylation | ISO | TBC1D31 (Homo sapiens) | 6480464 | bisphenol F results in increased methylation of TBC1D31 gene | CTD | PMID:31601247 | butan-1-ol | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of WDR67 mRNA | CTD | PMID:29432896 | carbon nanotube | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of TBC1D31 mRNA | CTD | PMID:25554681 | CGP 52608 | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to WDR67 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of TBC1D31 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Tbc1d31 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TBC1D31 mRNA | CTD | PMID:20938992 | cisplatin | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of TBC1D31 mRNA and Cisplatin results in increased expression of WDR67 mRNA | CTD | PMID:27392435 and PMID:27594783 | cisplatin | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of WDR67 mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of TBC1D31 mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of TBC1D31 mRNA | CTD | PMID:29279043 | diclofenac | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Diclofenac results in decreased expression of TBC1D31 mRNA | CTD | PMID:35537566 | dicrotophos | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of TBC1D31 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D31 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of TBC1D31 mRNA | CTD | PMID:29803840 | ethanol | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of WDR67 mRNA | CTD | PMID:29432896 | fluoranthene | multiple interactions | ISO | Tbc1d31 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of TBC1D31 mRNA | CTD | PMID:28329830 | folic acid | multiple interactions | ISO | Tbc1d31 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TBC1D31 mRNA | CTD | PMID:20938992 | folic acid | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of WDR67 mRNA | CTD | PMID:25629700 | fragrance | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Perfume results in increased expression of TBC1D31 mRNA | CTD | PMID:24768652 | genistein | increases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Genistein results in increased expression of WDR67 mRNA | CTD | PMID:32186404 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of TBC1D31 mRNA | CTD | PMID:21396975 | isobutanol | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of WDR67 mRNA | CTD | PMID:29432896 | L-methionine | multiple interactions | ISO | Tbc1d31 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TBC1D31 mRNA | CTD | PMID:20938992 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of TBC1D31 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of TBC1D31 mRNA | CTD | PMID:23649840 | methylparaben | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | methylparaben results in decreased expression of TBC1D31 mRNA | CTD | PMID:31745603 | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of TBC1D31 gene | CTD | PMID:33148267 | N-methyl-4-phenylpyridinium | increases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of TBC1D31 mRNA | CTD | PMID:22776087 | N-nitrosodiethylamine | increases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of TBC1D31 mRNA | CTD | PMID:24535843 | nickel atom | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Nickel results in increased expression of TBC1D31 mRNA | CTD | PMID:25583101 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TBC1D31 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Tbc1d31 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of TBC1D31 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of TBC1D31 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of TBC1D31 mRNA | CTD | PMID:22230336 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of TBC1D31 mRNA | CTD | PMID:33387578 | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of TBC1D31 gene | CTD | PMID:33148267 | phenylmercury acetate | decreases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of TBC1D31 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D31 mRNA | CTD | PMID:27188386 | pirinixic acid | increases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of TBC1D31 mRNA | CTD | PMID:23811191 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of TBC1D31 mRNA | CTD | PMID:30047161 | resveratrol | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of TBC1D31 mRNA | CTD | PMID:23557933 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of TBC1D31 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | TBC1D31 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBC1D31 mRNA | CTD | PMID:27188386 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of TBC1D31 mRNA | CTD | PMID:30047161 | temozolomide | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of TBC1D31 mRNA | CTD | PMID:31758290 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of TBC1D31 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of TBC1D31 mRNA | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of TBC1D31 mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of TBC1D31 mRNA | CTD | PMID:29264374 | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of TBC1D31 mRNA | CTD | PMID:25729387 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TBC1D31 mRNA | CTD | PMID:25729387 | trichostatin A | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of TBC1D31 mRNA | CTD | PMID:24935251 | trimellitic anhydride | increases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of TBC1D31 mRNA | CTD | PMID:19042947 | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of TBC1D31 mRNA | CTD | PMID:30589522 | triptonide | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | triptonide results in decreased expression of TBC1D31 mRNA | CTD | PMID:33045310 | troglitazone | increases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | troglitazone results in increased expression of TBC1D31 mRNA | CTD | PMID:28973697 | trovafloxacin | decreases expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of TBC1D31 mRNA | CTD | PMID:35537566 | valproic acid | affects expression | ISO | Tbc1d31 (Mus musculus) | 6480464 | Valproic Acid affects the expression of TBC1D31 mRNA | CTD | PMID:17963808 | valproic acid | affects expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TBC1D31 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | TBC1D31 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TBC1D31 mRNA | CTD | PMID:22083351 more ... | |